Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.

Series A Financing Deal Toy

Crystal deal toy commemorating Series A financing for Interius BioTherapeutics,  a preclinical stage gene therapy firm.

2 Images
Crystal deal tombstone celebrating Series A financing for Interius BioTherapeutics. The gene therapy developer is based in Philadelphia.

ASX IPO Crystal Commemorative

Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.

2 Images
Back view of custom crystal celebrating the initial public offering on the Australia Securities Exchange of Chimeric Therapeutics.

Logo-Themed Funding Tombstone

Lucite tombstone commemorating crossover funding for AbSci, a Vancouver, Washington-based biotech firm.

2 Images
Lucite deal toy marking crossover funding provided to biotech firm AbSci.

Biotech IPO Deal Tombstone

Crystal deal tombstone celebrating the initial public offering of Arctic Bioscience. The Norwegian biotech firm makes use of bioactive marine compounds, including herring roe extracts.

2 Images
Logo-themed del toy celebrating the listing on the Oslo-based Euronext Growth exchange of Arctic Bioscience. Based in Ørsta, Norway, the biotech firm develops products for pharmaceutical and nutraceutical applications.

Biotech Financial Tombstone

Custom financial tombstone commemorating an offering by Artelo Biosciences, a San Diego-based biopharmaceutical firm.

1 Image

Faceted Crystal Deal Toy

Custom deal toy celebrating a follow-on public offering by Applied UV, a technology company employing narrow-range ultra violet light (UVC) to combat pathogens.

1 Image

Lucite Tombstone for Biotech Series A Funding

Lucite tombstone celebrating Series A funding for Trailhead Biosystems. The Cleveland-based biotechnology company is focused on the application of machine-enabled technology.

1 Image

Faceted Circle Lucite Tombstone

Lucite tombstone celebrating a private placement and concurrent global offering of shares by Calliditas Therapeutics. Joint bookrunners in the offering by the Swedish biotech firm were Citi, Jefferies, and Stifel.

2 Images
Lucite deal toy celebrating a public offering of American Depositary Shares, and concurrent private placement, by Calliditas Therapeutics. The pharmaceutical firm is based in Stockholm, Sweden.

Gene Therapeutics Deal Toy

Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel.

1 Image

Biotech Deal Toys

Beginning on this page, you’ll find galleries with over 90 images of financial tombstones and deal toys from the biotech and life sciences space. You’ll find a number of custom designs playing off visual elements commonly associated with this space, including DNA strands, pills, lab beakers, periodic tables, as well as ones incorporating actual drug vials.

As you might also expect, you’ll see a number of deal toys involving internationally recognized firms and players. These include Takeda Pharmaceutical, Horizon Therapeutics, Gilead Sciences, Roche, Neurocrine, and Bayer. You’ll see as well tombstones commemorating transactions common to this sector involving these and other firms: joint ventures, licensing deals, and development and commercialization agreements.

But you’ll also notice a number of deals commemorated here that may involve far less familiar firms. These include the acquisition of a Dutch company focused on live-cell imaging analytics, and one of an Illinois-based gene therapy firm devoted to the treatment of a rare genetic disorder; the initial public offering of an Australian developer of radiopharmaceutical cancer therapies, and the IPO of a Norwegian biotech making use of marine compounds such as herring roe extract; early-stage funding for a Philadelphia gene engineering startup, and the IPO of an Israeli firm focused on medical applications for lipid-based compounds.

You’ll also notice in these galleries designs not related to any financial transaction. These celebrate a range of awards and employee recognition pieces honoring successful clinical trials, Food and Drug Administration (FDA) and New Drug Application (NDA) submissions, research collaborations and partnerships, and product development milestones.